Group#02

Topic: Statistical Comparison between Square Pharmaceuticals Ltd. & Beximco Pharmaceuticals Ltd.

By PresenterMedia.com

Group Members

1
2

Fahmida Akter Suchana

ID: 17-0089

Mahfuz Arefin
ID: 17-060

3 4
5

Shama Das
ID: 17-015

Chamak Dewan
ID: 17-095

Nowshin Mahbub
ID: 17-097

Agenda

Company Overview Financial Analysis:Beximco Pharmaceuticals Ltd. Financial Analysis: Square Pharmaceutical Ltd Interpretation of the financial Data Comparison between the companies

1 2 3 4 5

Beximco Pharmaceuticals Ltd.

Company Overview

Beximco Pharmaceuticals Ltd

Beximco Pharma aspires to become a nationally admired and globally reputed generic pharmaceutical company, committed to enhancing human health and life.
Beximco Pharmaceuticals Ltd., is a leading manufacturer and exporter of active pharmaceutical ingredients (APIs) in Bangladesh.

It is the only Bangladeshi company with an AIM listing on the London Stock Exchange.
The company employs more than 2,500 people

The company was incorporated in 1976 and listed on DSE in 1985.

Highlights of the financial data

Beximco Pharmaceuticals Ltd.
(In billion) 2006 2007 2008 2009 2010 Total

Net profit after tax

.47

.35

.55

.62

1.05

3.04

Gross profit
Cost of goods sold Operating expense Other Income

1.73
1.97 .98 .06

1.63
1.97 .97 .02

2
2 1 .000686

2.3
2.57 1.3 .2

3.17
3.32 1.54 .46

10.83
11.83 5.79 .74

Net Profit After Tax

1.2

1 0.8
0.6 0.4

0.2 0
2006 2007 2008 2009 2010

Mean of the Variables

Variables Mean
(In Billion Tk)

Net profit after tax Gross profit

4.96 2.79 2.05

Cost of goods sold Operating expense Other Income

1.02 5.65

Variance & Standard Deviation

The population Variance of net profit after tax is 0.0569. And the Standard Deviation is 0.24.

Variance & Standard Deviation are based on the deviations from the mean. Here, we use the square value of the deviations.

Coefficient of Correlation
Cost of goods Profit after tax sold 1 .663 Operating expense .646 Other income .642

Profit after tax

Cost of goods sold

Operating expense

.995

.940

.913

Other income

Chart Title
1.2 1 0.8 0.6 0.4 0.2 0 Axis Title

profit after tax 0.646 1 0.663 0.642

cost of goods sold 0.995 0.663 1 0.94

operating expense 1 0.646 0.995 0.913

other income 0.913 0.642 0.94 1

operting expense profit after tax cost of goods sold other income

Here Magnitude of R is .465 And Magnitude of Adjusted R Square -1.140

As R square is greater than adjusted R square, new variables can have no effect on the prediction. So, there is no need of adding new variables.

Square Pharmaceuticals Ltd.

Company Overview

Square Pharmaceuticals Ltd.

The Companys mission is to produce and provide quality & innovative healthcare relief for people, maintain stringently ethical standard in business operation also ensuring benefit to the shareholders, stakeholders and the society at large.
Established as a partnership company in 1958.

Incorporate as a private Limited company in 1964.

Converted into a Public Limited Company in 1991.

The Company was listed in Stock Exchange in 1995.

Highlights of the financial Data

Square Pharmaceuticals Limited
(In billion Tk.) Net profit after tax Gross profit
Cost of goods sold Operating expense Other Income

2006 1.17 2.56

3.53 .98 .17

2007 1.13 3.23

4.27 1.41 .22

2008 1.38 3.4

4.86 1.69 .6

2009 1.89 4.15

5.67 1.78 .67

2010 2.09 4.9

6.56 2.21 .59

Total 7.66 18.24

24.89 8.07 2.25

Net Profit After Tax

2.5 2
1.5 1 0.5 0 2006 2007 2008 2009 2010

Mean of the Variables

Variables Mean

Net profit after tax Gross profit Cost of goods sold

1.57

4.98
4.98

Operating expense Other Income

1.62

4.49

Coefficient of Correlation
Cost of goods Profit after tax sold 1 .971
1

Profit after tax Cost of goods sold Operating expense Oter income

Operating expense .902

.979 1

Other income .758 .824 .826 1

Chart Title
1.2 1 0.8 0.6 0.4 0.2 0 Axis Title

Profit after tax 1 0.971 0.902 0.758

cost of goods sold 0.971 1 0.979 0.824

operating expense 0.902 0.979 1 0.826

other income 0.758 0.824 0.826 1

profit after tax cost of goods sold operating expense other income

Here R square is .999 And Adjusted R square is .996 Since R square, is greater than adjusted R Square, new variables can not have any effect on the prediction.

Comparison

Mean
Variables Profit after tax Gross profit Cost of goods sold Beximco Pharma 4.96 2.79 2.05 Square Pharma

1.57

4.98
4.98 1.62 4.49

Operating expense
Other income

1.02
5.65

Comparison between Net Profit after Tax

3.5

3
2.5 2 Square 1.5 1 Beximco

0.5
0 2006 2007 2008 2009 2010

Variance & Standard Deviation

The population Variance of net profit after tax is 0.151 And the Standard Deviation is 0.39

Variance & Standard Deviation are based on the deviations from the mean. Here, we use the square value of the deviations.

Comparison between corrrelation

Beximco
Among the variables operating expense influence Net profit after tax more. The correlation between operating expense & net profit after tax is .646. Square Among the variables cost of goods sold influence net profit after tax more. The correlation between cost of goods sold & net profit after tax is .971.

Return on Equity

The

ratio of return on equity of Beximco is 5.55%.

The ROE of Square is 17.89%.

Quartile
Beximco Pharmaceuticals Ltd.
Q1 Q2 .55 2 2 1 .06 Q3 .62 2.3 2.57 1.3 .2

Net profit after tax Gross profit Cost of goods sold Operating expense Other Income

.35 1.63 1.97 .97 .02

Quartile
Square Pharmaceuticals Limited
Q1 Q2 1.38 Q3 1.89

Net profit after tax Gross profit Cost of goods sold Operating expense Other Income

1.17

3.23 4.27 1.41

.22

3.4 4.86 1.69

.59

4.15 5.67 1.78

.6